Organon Balans Gezondheid
Financiële gezondheid criteriumcontroles 1/6
Organon heeft een totaal eigen vermogen van $493.0M en een totale schuld van $8.7B, wat de schuld-eigenvermogensverhouding op 1774.6% brengt. De totale activa en totale passiva bedragen respectievelijk $12.8B en $12.3B. De EBIT Organon is $1.5B waardoor de rentedekking 2.9 is. Het heeft contanten en kortetermijnbeleggingen van $763.0M.
Belangrijke informatie
1,774.6%
Verhouding schuld/eigen vermogen
US$8.75b
Schuld
| Rente dekkingsratio | 2.9x |
| Contant | US$763.00m |
| Aandelen | US$493.00m |
| Totaal verplichtingen | US$12.26b |
| Totaal activa | US$12.75b |
Recente financiële gezondheidsupdates
Recent updates
Organon: Certainly A Risky Bet, But Looks Increasingly Compelling (Upgrade)
Nov 13The Organon & Co. (NYSE:OGN) Third-Quarter Results Are Out And Analysts Have Published New Forecasts
Nov 04
Roivant's Sale Of Dermavant To Organon: A Strategic Win-Win In Atopic Dermatitis
Sep 19These 4 Measures Indicate That Organon (NYSE:OGN) Is Using Debt In A Risky Way
Sep 13Organon & Co.: Cheap With Caveats
Aug 22Organon (NYSE:OGN) Will Pay A Dividend Of $0.28
Aug 09Insufficient Growth At Organon & Co. (NYSE:OGN) Hampers Share Price
Aug 07Organon: Upcoming Q2 Earnings Can Sustain Upward Momentum
Jul 30Organon & Co.'s (NYSE:OGN) CEO Might Not Expect Shareholders To Be So Generous This Year
May 29Organon's (NYSE:OGN) Solid Profits Have Weak Fundamentals
May 10Four Reasons Why Organon Stock Is A Good Buy
May 07Little Excitement Around Organon & Co.'s (NYSE:OGN) Earnings
Apr 21Organon Stock Is Still Worth A Look
Feb 24Organon (NYSE:OGN) Is Due To Pay A Dividend Of $0.28
Feb 19Organon Q4 And Full Year 2023 Earnings Review - Positive Updates At Last
Feb 16Organon: What I'm Looking For In This 8% Yield In 2024
Jan 03High Risk, High Reward: Why 8.5%-Yielding Organon Could Be Up To 90% Undervalued
Dec 19Organon: It's Darkest Before The Dawn
Nov 30Organon: Poor Q3 Earnings Make Bear Case, But Dividend Is Saving Grace
Nov 07Organon (NYSE:OGN) Has Affirmed Its Dividend Of $0.28
Nov 05Organon: The Federal Reserve Black Swan (Rating Upgrade)
Oct 046% Yield And Significantly Undervalued: A Closer Look At Organon
Sep 10Organon Q2 2023 Earnings Review: Incremental Growth With A Slather Of Risk
Aug 10Organon & Co.: A Tough Spot To Be In Right Now
Jul 16Organon goes ex-dividend tomorrow
Feb 23Organon & Co. (NYSE:OGN) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?
Feb 19Is There Anything Organic Or Interesting About Organon?
Feb 07Organon goes ex-dividend tomorrow
Nov 09Organon's (NYSE:OGN) Dividend Will Be $0.28
Nov 08Take Care Before Diving Into The Deep End On Organon & Co. (NYSE:OGN)
Nov 05Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( $4.8B ) OGN } overtreffen de korte termijn passiva ( $2.8B ).
Langlopende schulden: De kortetermijnactiva van OGN ( $4.8B ) dekken de langetermijnschulden ( $9.5B ) niet.
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: De netto schuld/eigen vermogen ratio ( 1619.9% ) OGN wordt als hoog beschouwd.
Schuld verminderen: De schuld/eigen vermogen-ratio van OGN is de afgelopen 5 jaar gestegen van 2.6% naar 1774.6%.
Schuldendekking: De schuld van OGN wordt niet goed gedekt door de operationele kasstroom ( 10.8% ).
Rentedekking: De rentebetalingen van OGN op haar schulden worden niet goed gedekt door EBIT ( 2.9 x dekking).